Downregulation of Microglial Activation by Achillolide A

Abstract

Chronic inflammation has been implicated in the pathogenesis of various neurodegenerative diseases. During the neuroinflammatory process, microglial cells release neurotoxic and proinflammatory mediators. In the present study, using activity-guided fractionation, we have purified an anti-inflammatory compound determined by spectroscopic methods to be a sesquiterpene lactone named achillolide A from Achillea fragrantissima (Forsk.) Sch. Bip. In primary cultures of lipopolysaccharide-activated microglial cells, achillolide A inhibited the lipopolysaccharide-induced levels of proinflammatory and toxic mediators including glutamate, nitric oxide, matrix metalloproteinase-9, cyclooxygenase-2, induced nitric oxide synthase, interleukin-1β, and tumor necrosis factor-α. Achillolide A also exhibited an antioxidant capacity, as was shown in a cell free system as well as by its ability to reduce intracellular reactive oxygen species levels in microglial cells. Thus, achillolide A might have therapeutic potential for treatment of neurodegenerative diseases and deserves further studies.

Key words

Achillea fragrantissima - Asteraceae - achillolide A - microglial cells - inflammation - neurodegenerative diseases

• References

• 1 Halliwell B. Oxidative stress and neurodegeneration: where are we now?. J Neurochem 2006; 97: 1634-1658
• 2 Ischiropoulos H, Beckman JS. Oxidative stress and nitration in neurodegeneration: cause, effect, or association?. J Clin Invest 2003; 111: 163-169
• 3 Minghetti L. Role of inflammation in neurodegenerative diseases. Curr Opin Neurol 2005; 18: 315-321
• 4 Agostinho P, Cunha R, Oliviera C. Neuroinflammation, oxidative stress and the pathogenesis of Alzheimerʼs disease. Curr Pharm Design 2010; 16: 2766-2778
• 5 Kaneko YS, Nakashima A, Mori K, Nagatsu T, Nagatsu I, Ota A. Microglial activation in neuroinflammation: implications for the etiology of neurodegeneration. Neurodegener Dis 2012; 10: 100-103
• 6 Boche D, Perry V, Nicoll J. Review: activation patterns of microglia and their identification in the human brain. Neuropath Appl Neuro 2013; 39: 3-18
• 7 Glass C, Saijo K, Winner B, Marchetto M, Gage F. Mechanisms underlying inflammation in neurodegeneration. Cell 2010; 140: 918-934
• 8 Block ML, Hong JS. Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism. Prog Neurobiol 2005; 76: 77-98
• 9 Aguzzi A, Barres BA, Bennett MK. Microglia: scapegoat, saboteur, or something else?. Science 2013; 339: 156-161
• 10 Yenary MA, Kauppinen TM, Swanson RA. Microglial activation in stroke: therapeutic targets. Neurotherapeutics 2010; 7: 378-391
• 11 Rizzo F, Riboldi G, Salani S, Nizzardo M, Simone C, Corti S, Hedlund E. Cellular therapy to target neuroinflammation in amyotrophic lateral sclerosis. Cell Mol Life Sci 2014; 71: 999-1015
• 12 Shabana MM, Mirhom YW, Genenah AA, Aboutabl EA, Amer HA. Study into wild Egyptian plants of potential medicinal activity. Ninth communication: hypoglycaemic activity of some selected plants in normal fasting and alloxanised rats. Arch Exp Veterinärmedizin 1990; 44: 389-394
• 13 Mustafa EH, Abu Zarga M, Abdalla S. Effects of cirsiliol, a flavone isolated from Achillea fragrantissima on rat isolated ileum. Gen Pharmacol 1992; 23: 555-560
• 14 Yaniv Z, Dafni A, Friedman J, Palevitch D. Plants used for the treatment of diabetes in Israel. J Ethnopharmacol 1987; 19: 145-151
• 15 Hamdan I, Afifi FU. Studies on the in vitro and in vivo hypoglycemic activities of some medicinal plants used in treatment of diabetes in Jordanian traditional medicine. J Ethnopharmacol 2004; 93: 117-121
• 16 Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, Haydon PG, Stout jr. RF, Spray DC, Reichenbach A, Pannicke T, Pekny M, Pekna M, Zorec R, Verkhratsky A. Glial cells in (patho)physiology. J Neurochem 2012; 121: 4-27
• 17 Elmann A, Telerman A, Mordechay S, Erlank H, Rindner M, Ofir R, Beit-Yannai E. Extract of Achillea fragrantissima downregulates ROS production and protects astrocytes from oxidative-stress-induced cell death. In: Chang RC-C, editor Neurodegenerative diseases – processes, prevention, protection and monitoring. Rijeka: InTech; 2011
• 18 Segal RA, Dor A, Duddeck DH, Snatzke G, Rosenbaum D, Kajtar M. The sesquiterpene lactones from Achillea fragrantissima, I. Achillolide A and B, two novel germacranolides. Tetrahedron 1987; 43: 4125-4132
• 19 McMullan S, Phanavanh B, Li G, Barger S. Metabotropic glutamate receptors inhibit microglial glutamate release. ASN Neuro 2010; 4: e00094
• 20 Elmann A, Telerman A, Mordechay S, Erlank H, Ofir R. Antioxidant and astro-protective effects of a Pulicaria incisa infusion. Ox Med Cell Longev 2012; 2012: 157598
• 21 Hadass O, Tomlinson BN, Gooyit M, Chen S, Purdy JJ, Walker JM, Zhang C, Giritharan AB, Purnell W, Robinson 2nd CR, Shin D, Schroeder VA, Suckow MA, Simonyi A, Sun GY, Mobashery S, Cui J, Chang M, Gu Z. Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injury. PLoS One 2013; 8: e76904
• 22 Wolfe KL, Liu RH. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J Agri Food Chem 2007; 55: 8896-8907
• 23 Merfort I. Perspectives on sesquiterpene lactones in inflammation and cancer. Curr Drug Targets 2011; 12: 1560-1573
• 24 Shi JQ, Zhang CC, Sun XL, Cheng XX, Wang JB, Zhang YD, Xu J, Zou HQ. Antimalarial drug artemisinin extenuates amyloidogenesis and neuroinflammation in APPswe/PS1 dE9 transgenic mice via inhibition of nuclear factor-kappaB and NLRP3 inflammasome activation. CNS Neurosci Ther 2013; 19: 262-268
• 25 Rayan NA, Baby N, Pitchai D, Indraswari F, Ling EA, Lu J, Dheen T. Costunolide inhibits proinflammatory cytokines and iNOS in activated murine BV2 microglia. Front Biosci (Elite Ed) 2011; 3: 1079-1091
• 26 Wang S, Li J, Sun J, Zeng K, Cui JR, Jiang Y, Tu PF. NO inhibitory guaianolide-derived terpenoids from Artemisia argyi . Fitoterapia 2013; 85: 169-175
• 27 Kim SK, Cho SB, Moon HI. Neuroprotective effects of a sesquiterpene lactone and flavanones from Paulownia tomentosa Steud. against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Phytother Res 2010; 24: 1898-1900
• 28 Amorim MH, Gil da Costa RM, Lopes C, Bastos MM. Sesquiterpene lactones: adverse health effects and toxicity mechanisms. Crit Rev Toxicol 2013; 43: 559-579
• 29 Ghantous A, Gali-Muhtasib H, Vuorela H, Saliba NA, Darwiche N. What made sesquiterpene lactones reach cancer clinical trials?. Drug Discov Today 2010; 15: 668-678
• 30 Auer M, Pfister LA, Leppert D, Tauber MG, Leib SL. Effects of clinically used antioxidants in experimental pneumococcal meningitis. J Infect Dis 2000; 182: 347-350
• 31 Leib SL, Clements JM, Lindberg RL, Heimgartner C, Loeffler JM, Pfister LA, Tauber MG, Leppert D. Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. Brain 2001; 124: 1734-1742
• 32 Aid S, Bosetti F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: Therapeutic implications. Biochimie 2011; 93: 46-51
• 33 Allan SM, Pinteaux E. The interleukin-1 system: an attractive and viable therapeutic target in neurodegenerative disease. Curr Drug Targets CNS Neurol Disord 2003; 2: 293-302
• 34 Rothwell NJ, Luheshi GN. Interleukin 1 in the brain: biology, pathology and therapeutic target. Trends Neurosci 2000; 23: 618-625
• 35 Siedle B, Garcia-Pineres AJ, Murillo R, Schulte-Mönting J, Castro V, Rüngeler P, Klaas CA, Da Costa FB, Kisiel W, Merfort I. Quantitative structure-activity relationship of sesquiterpene lactones as inhibitors of the transcription factor NF-kappaB. J Med Chem 2004; 47: 6042-6054
• 36 Elmann A, Mordechay S, Rindner M, Ravid U. Anti-neuroinflammatory effects of geranium oil in microglial cells. J Func Foods 2010; 2: 17-22
• 37 Elmann A, Mordechay S, Erlank H, Telerman A, Rindner M, Ofir R. Anti-neuroinflammatory effects of the extract of Achillea fragrantissima . BMC Complement Altern Med 2011; 11: 98
• 38 Kueng W, Silber E, Eppenberger U. Quantification of cells cultured on 96-well plates. Anal Biochem 1989; 182: 16-19
• 39 Bowry VW, Stocker R. Tocopherol-mediated peroxidation. The prooxidant effect of vitamin E on the radical-initiated oxidation of human low density lipoproteins. J Am Chem Soc 1993; 115: 6029-6044
• 40 Niki E, Saito M, Yoshikawa Y, Yamamoto Y, Kamiya Y. Oxidation of lipids XII. Inhibition of oxidation of soybean phosphatidylcholine and methyl linoleate in aqueous dispersions by uric acid. Bull Chem Soc Jpn 1986; 59: 471-477
• 41 Thomas MJ, Chen Q, Franklin C, Rudel LL. A comparison of the kinetics of low-density lipoprotein oxidation initiated by copper or by azobis (2-amidinopropane). Free Radic Biol Med 1997; 23: 927-935